Bayer Pharma AG, Germany
For women of childbearing age, adults prescribed by a doctor, for women
tablets, film-coated, each active tablet contains:
ethinylestradiol 0.03 mg,
3.00 mg drospirenone.
Thrombosis and embolism, as well as conditions prior thrombosis present or in history, cerebrovascular disorders; migraine with focal neurological symptoms in the present or in history; diabetes with vascular complications; multiple or severe risk factors for venous or arterial thrombosis, including complicated valvular lesions; atrial fibrillation; cerebrovascular disease or coronary artery; uncontrolled hypertension; major surgery with prolonged immobilization; smoking at the age of 35 years; pancreatitis with severe hypertriglyceridemia at present or in history; hepatic failure and severe liver disease (as long as hepatic tests do not return to normal); liver tumors (benign or malignant) now or in the anamnesis; severe renal insufficiency, acute renal failure; adrenal insufficiency; identified hormone-malignant diseases (including genital or mammary glands) or suspicion on them; vaginal bleeding of unknown origin; pregnancy or suspicion of it; lactation; hypersensitivity to any component of Yasmin preparation.
Application with caution. If any of the conditions / risk factors mentioned below are currently available, you should carefully weigh the potential risks and expected benefits of the use of combined oral contraceptives in each individual case: risk factors for thrombosis and thromboembolism; diseases, which may occur when the peripheral circulatory disorders; hereditary angioneurotic edema; hypertriglyceridemia, liver disease; the disease first appeared or worsen during pregnancy, or on the background of the previous use of sex hormones (eg, jaundice, cholestasis, cholelithiasis, otosclerosis with hearing impairment, porphyria, herpes gestationis, Sydenham’s chorea); postpartum period.
May experience menstrual irregularities, such as irregular bleeding (spotting or bleeding), especially during the first few months of use.
While taking combined oral contraceptives in women were observed and other undesirable effects, whose connection with the drug is not confirmed, but not refuted.
Detailed information is contained in the instructions for use.
How to accept, acceptance rate and dosage
Dragees should be taken orally in the order indicated on the package, every day at about the same time, with a little water.
Take one tablet a day continuously for 21 days.
Receiving the next pack is started after a 7-day break in taking pills, during which usually occurs withdrawal bleeding.
In case of skipping the drug must be guided reception rules missed pills.
At room temperature no higher than 25 ° C